Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Accelagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (49)
Prescription medicine registration (20)
Cancellation by sponsor (5)
Prescription medicine evaluation (4)
COVID-19 test kit (1)

Date

2024 (6)
2023 (1)
2022 (29)
2021 (17)
2020 (16)
2019 (4)
2016 (2)
2001 (4)

Results for "[search-keyword]"

Search

Sponsor content

79 result(s) found, displaying 41 to 50

MSN DASATINIB dasatinib 20 mg film-coated tablet blister pack (335104)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN DASATINIB dasatinib 20 mg film-coated tablet blister pack.
SUGAMMADEX MSN (Accelagen Pty Ltd)

26 April 2022

Prescription medicine registration

Active ingredients: sugammadex sodium.
AMBRISENTAN MSN (Accelagen Pty Ltd)

4 March 2022

Prescription medicine registration

Active ingredients: ambrisentan.
DEFERASIROX FCT MSN (Accelagen Pty Ltd)

3 March 2022

Prescription medicine registration

Active ingredients: deferasirox.
LACOSAMIDE MSN (Accelagen Pty Ltd)

20 January 2022

Prescription medicine registration

Active ingredients: lacosamide.
LACOSAMIDE MSN (Accelagen Pty Ltd)

20 January 2022

Prescription medicine registration

Active ingredients: lacosamide.
ERLOTINIB ARX erlotinib (as hydrochloride) 100 mg film-coated tablet blister pack (324446)

13 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERLOTINIB ARX erlotinib (as hydrochloride) 100 mg film-coated tablet blister pack.
ERLOTINIB ARX erlotinib (as hydrochloride) 150 mg film-coated tablet blister pack (324445)

13 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERLOTINIB ARX erlotinib (as hydrochloride) 150 mg film-coated tablet blister pack.
ERLOTINIB ARX erlotinib (as hydrochloride) 25 mg film-coated tablet blister pack (324444)

12 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERLOTINIB ARX erlotinib (as hydrochloride) 25 mg film-coated tablet blister pack.
AZACITIDINE MSN; AZACITIDINE SANDOZ (Accelagen Pty Ltd)

20 October 2021

Prescription medicine registration

Active ingredients: azacitidine.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.